Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HMGCR | P04035 | 4/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.32 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9753491 | 1.00 | POLB (0.34) | POLBHMGCRPTGS2KDM5BPIK3CD | |
| SCHEMBL9753408 | 0.89 | POLB (0.39) | POLBHMGCRPTGS2KDM5B | |
| SCHEMBL9752990 | 0.87 | KDM5B (0.34) | POLBHMGCRPTGS2KDM5B | |
| SCHEMBL9752989 | 0.87 | KDM5B (0.34) | POLBHMGCRPTGS2KDM5B | |
| SCHEMBL9753686 | 0.85 | MAPK14 (0.40) | POLBPTGS2KDM5BKMT2A | |
| SCHEMBL9753682 | 0.85 | MAPK14 (0.40) | POLBPTGS2KDM5BKMT2A | |
| SCHEMBL9753463 | 0.84 | PTGS2 (0.34) | PTGS2KDM5B | |
| SCHEMBL9753226 | 0.84 | MAPK14 (0.39) | PTGS2KDM5BKMT2A | |
| SCHEMBL9753466 | 0.84 | PTGS2 (0.34) | PTGS2KDM5B | |
| SCHEMBL9753228 | 0.84 | MAPK14 (0.39) | PTGS2KDM5BKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1991018903-A1 | PYRROLOPYRIDAZINE COMPOUNDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-12-12 | — | — | WO | disclosed |